{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:10:27Z","timestamp":1778735427383,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T00:00:00Z","timestamp":1458172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11655-015-2299-7","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T17:32:10Z","timestamp":1458322330000},"page":"770-778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway"],"prefix":"10.1007","volume":"23","author":[{"given":"Jun-biao","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-ling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-mei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-fang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiu-yao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,17]]},"reference":[{"key":"2299_CR1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/CIRCRESAHA.111.248872","volume":"109","author":"D Lee","year":"2011","unstructured":"Lee D, Goldberg A. Atrogin1\/MAFbx: what atrophy, hypertrophy, and cardiac failure have in common. Circ Res 2011;109:123\u2013126.","journal-title":"Circ Res"},{"key":"2299_CR2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1152\/physiol.00033.2006","volume":"22","author":"A Diwan","year":"2007","unstructured":"Diwan A, Dorn GW 2nd. Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology (Bethesda) 2007;22:56\u201364.","journal-title":"Physiology (Bethesda)"},{"key":"2299_CR3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/15376516.2012.666650","volume":"22","author":"SK Maulik","year":"2012","unstructured":"Maulik SK, Kumar S. Oxidative stress and cardiac hypertrophy: a review. Toxicol Mechan Methods 2012;22:359\u2013366.","journal-title":"Toxicol Mechan Methods"},{"key":"2299_CR4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopha.2012.08.009","volume":"66","author":"E Tousson","year":"2012","unstructured":"Tousson E, Ali EM, Ibrahim W, Ashraf RM. Histopathological and immunohistochemical alterations in rat heart after thyroidectomy and the role of hemin and ketoconazole in treatment. Biomed Pharm 2012;66:627\u2013632.","journal-title":"Biomed Pharm"},{"key":"2299_CR5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ecl.2006.09.008","volume":"35","author":"B Nayak","year":"2006","unstructured":"Nayak B, Burman K. Thyrotoxicosis and thyroid storm. Endocrinol Metabol Clin North Am 2006;35:663\u2013686.","journal-title":"Endocrinol Metabol Clin North Am"},{"key":"2299_CR6","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"I Klein","year":"2007","unstructured":"Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007;116:1725\u20131735.","journal-title":"Circulation"},{"key":"2299_CR7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00210-012-0740-4","volume":"385","author":"S Wang","year":"2012","unstructured":"Wang S, Han HM, Pan ZW, Hang PZ, Sun LH, Jiang YN, et al. Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway. Naunyn-Schmiedeberg's Arch Pharmacol 2012;385:823\u2013831.","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"2299_CR8","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1128\/MCB.00031-13","volume":"33","author":"I Perez Lopez","year":"2013","unstructured":"Perez Lopez I, Cariolato L, Maric D, Gillet L, Abriel H, Diviani D. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy. Mol Cell Biol 2013;33:2903\u20132917.","journal-title":"Mol Cell Biol"},{"key":"2299_CR9","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1074\/jbc.273.4.2161","volume":"273","author":"Y Wang","year":"1998","unstructured":"Wang Y, Huang S, Sah VP, Ross J, Jr., Brown JH, Han J, et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. Biol Chem 1998;273:2161\u20132168.","journal-title":"Biol Chem"},{"key":"2299_CR10","volume-title":"Pharmacopoeia of People's Republic of China","author":"National Pharmacopoeia Committee,.","year":"2010","unstructured":"National Pharmacopoeia Committee, ed. Pharmacopoeia of People's Republic of China. Beijing: Chemical Industry Press; 2010."},{"key":"2299_CR11","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.fitote.2011.04.016","volume":"82","author":"B Yu","year":"2011","unstructured":"Yu B, Fang TH, Lu GH, Xu HQ, Lu JF. Beneficial effect of cyclovirobuxine D on heart failure rats following myocardial infarction. Fitoterapia 2011;82:868\u2013877.","journal-title":"Fitoterapia"},{"key":"2299_CR12","first-page":"919","volume":"14","author":"Y Zhou","year":"2011","unstructured":"Zhou Y, Wu JB, Liu AJ, Chen XJ, Pan LX, Zhou JY. Preliminary study protective effect of cyclovirobuxinum D on cardiac hypertrophy induced by isoprenaline in mice. China Pharm (Chin) 2011;14:919\u2013921.","journal-title":"China Pharm (Chin)"},{"key":"2299_CR13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/hrt.2006.100628","volume":"93","author":"CW Siu","year":"2007","unstructured":"Siu CW, Yeung CY, Lau CP, Kung AW, Tse HF. Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Heart 2007;93:483\u2013487.","journal-title":"Heart"},{"key":"2299_CR14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mce.2010.01.031","volume":"320","author":"YY Wang","year":"2010","unstructured":"Wang YY, Jiao B, Guo WG, Che HL, Yu ZB. Excessive thyroxine enhances susceptibility to apoptosis and decreases contractility of cardiomyocytes. Mol Cell Endocrinol 2010;320:67\u201375.","journal-title":"Mol Cell Endocrinol"},{"key":"2299_CR15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-6614-5-8","volume":"5","author":"J Ker","year":"2012","unstructured":"Ker J. Thyroxine and cardiac electrophysiology\u2014a forgotten physiological duo? Thyroid Res 2012;5:8.","journal-title":"Thyroid Res"},{"key":"2299_CR16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/hrt.75.4.363","volume":"75","author":"GW Ching","year":"1996","unstructured":"Ching GW, Franklyn JA, Stallard TJ, Daykin J, Sheppard MC, Gammage MD. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart 1996;75:363\u2013368.","journal-title":"Heart"},{"key":"2299_CR17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00395-010-0089-0","volume":"105","author":"MS Carneiro-Ramos","year":"2010","unstructured":"Carneiro-Ramos MS, Diniz GP, Nadu AP, Almeida J, Vieira RL, Santos RA, et al. Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Res Cardiol 2010;105:325\u2013335.","journal-title":"Basic Res Cardiol"},{"key":"2299_CR18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2007.04.038","volume":"569","author":"D Hu","year":"2007","unstructured":"Hu D, Liu X, Wang Y, Chen S. Cyclovirobuxine D ameliorates acute myocardial ischemia by KATP channel opening, nitric oxide release and anti-thrombosis. Eur J Pharmacol 2007;569:103\u2013109.","journal-title":"Eur J Pharmacol"},{"key":"2299_CR19","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.fitote.2012.09.019","volume":"83","author":"B Yu","year":"2012","unstructured":"Yu B, Ruan M, Zhou L, Xu L, Fang T. Influence of cyclovirobuxine D on intracellular Ca2+ regulation and the expression of the calcium cycling proteins in rat myocytes. Fitoterapia 2012;83:1653\u20131665.","journal-title":"Fitoterapia"},{"key":"2299_CR20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/1097-4652(200101)186:1<11::AID-JCP1013>3.0.CO;2-5","volume":"186","author":"K Hasegawa","year":"2001","unstructured":"Hasegawa K, Iwai-Kanai E, Sasayama S. Neurohormonal regulation of myocardial cell apoptosis during the development of heart failure. J Cell Physiol 2001;186:11\u201318.","journal-title":"J Cell Physiol"},{"key":"2299_CR21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-013-1686-7","volume":"381","author":"F Lu","year":"2013","unstructured":"Lu F, Xing J, Zhang X, Dong S, Zhao Y, Wang L, et al. Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol. Mol Cell Biochem 2013;381:41\u201350.","journal-title":"Mol Cell Biochem"},{"key":"2299_CR22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0092-8674(00)80729-1","volume":"97","author":"H Hirota","year":"1999","unstructured":"Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J Jr., et al. Loss of a GP130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 1999;97:189\u2013198.","journal-title":"Cell"},{"key":"2299_CR23","doi-asserted-by":"crossref","first-page":"34882","DOI":"10.1074\/jbc.M404616200","volume":"279","author":"M Mayorga","year":"2004","unstructured":"Mayorga M, Bahi N, Ballester M, Comella JX, Sanchis D. Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death. J Biol Chem 2004;279:34882\u201334889.","journal-title":"J Biol Chem"},{"key":"2299_CR24","first-page":"197","volume":"19","author":"RA Yu","year":"2006","unstructured":"Yu RA, Yang CF, Chen XM. DNA damage, apoptosis and c-myc, c-fos, and c-jun overexpression induced by selenium in rat hepatocytes. Biomed Environ Sci 2006;19:197\u2013204.","journal-title":"Biomed Environ Sci"},{"key":"2299_CR25","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ijc.28097","volume":"133","author":"MC Errico","year":"2013","unstructured":"Errico MC, Felicetti F, Bottero L, Mattia G, Boe A, Felli N, et al. The abrogation of the HOXB7\/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-Fos pathway. Int J Cancer 2013;133:879\u2013892.","journal-title":"Int J Cancer"},{"key":"2299_CR26","doi-asserted-by":"crossref","first-page":"20343","DOI":"10.1074\/jbc.M110.116988","volume":"285","author":"M Asim","year":"2010","unstructured":"Asim M, Chaturvedi R, Hoge S, Lewis ND, Singh K, Barry DP, et al. Helicobacter pylori induces ERK-dependent formation of a phospho-c-Fos c-Jun activator protein-1 complex that causes apoptosis in macrophages. J Biol Chem 2010;285:20343\u201320357.","journal-title":"J Biol Chem"},{"key":"2299_CR27","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/eurheartj\/ehm343","volume":"28","author":"S Pilz","year":"2007","unstructured":"Pilz S, Scharnagl H, Tiran B, Wellnitz B, Seelhorst U, Boehm BO, et al. Elevated plasma free fatty acids predict sudden cardiac death: a 6.85-year follow-up of 3315 patients after coronary angiography. Eur Heart J 2007;28:2763\u20132769.","journal-title":"Eur Heart J"},{"key":"2299_CR28","first-page":"401","volume":"28","author":"H Luo","year":"1997","unstructured":"Luo H, Guo H, Xiao J, Xue Z. Circadian variations of plasma SOD and MDA in health subjects. J West China Univ Med Sci (Chin) 1997;28:401\u2013403.","journal-title":"J West China Univ Med Sci (Chin)"},{"key":"2299_CR29","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1126\/science.1063279","volume":"292","author":"CR Weston","year":"2001","unstructured":"Weston CR, Davis RJ. Signal transduction: signaling specificity\u2014a complex affair. Science 2001;292:2439\u20132440.","journal-title":"Science"},{"key":"2299_CR30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/35104735","volume":"414","author":"JM Kyriakis","year":"2001","unstructured":"Kyriakis JM. Life-or-death decisions. Nature 2001;414:265\u2013266.","journal-title":"Nature"},{"key":"2299_CR31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cardfail.2006.04.006","volume":"12","author":"Q Liang","year":"2006","unstructured":"Liang Q, Elson AC, Gerdes AM. p38 MAP kinase activity is correlated with angiotensin II type 1 receptor blockerinduced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats. J Cardiac Fail 2006;12:479\u2013486.","journal-title":"J Cardiac Fail"},{"key":"2299_CR32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/FJC.0b013e318046f34a","volume":"49","author":"W Bao","year":"2007","unstructured":"Bao W, Behm DJ, Nerurkar SS, Ao Z, Bentley R, Mirabile RC, et al. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production. J Cardiovascul Pharmacol 2007;49:362\u2013368.","journal-title":"J Cardiovascul Pharmacol"},{"key":"2299_CR33","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1161\/CIRCRESAHA.109.213199","volume":"106","author":"JM Streicher","year":"2010","unstructured":"Streicher JM, Ren S, Herschman H, Wang Y. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circul Res 2010;106:1434\u20131443.","journal-title":"Circul Res"},{"key":"2299_CR34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/CIRCRESAHA.110.226803","volume":"108","author":"JG Dickhout","year":"2011","unstructured":"Dickhout JG, Carlisle RE, Austin RC. Interrelationship between cardiac hypertrophy, heart failure, and chronic kidney disease: endoplasmic reticulum stress as a mediator of pathogenesis. Circul Res 2011;108:629\u2013642.","journal-title":"Circul Res"},{"key":"2299_CR35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/cvr\/cvn243","volume":"81","author":"GW Dorn","year":"2009","unstructured":"Dorn GW, 2nd. Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovascul Res 2009;81:465\u2013473.","journal-title":"Cardiovascul Res"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-015-2299-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-015-2299-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-015-2299-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-015-2299-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:00:54Z","timestamp":1559415654000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-015-2299-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,17]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["2299"],"URL":"https:\/\/doi.org\/10.1007\/s11655-015-2299-7","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,17]]}}}